News
The lower rating came from HSBC, which cited too much optimism around its new weight-loss pill, and the strength of Novo ...
A decision is expected in the fourth quarter of 2025.
All these drugs are very effective and they’ve become a game changer for people who need to lose weight. Get on the drug, eat ...
6d
inews.co.uk on MSNThe unexpected benefits of weight loss jabs - and the downsidesDoctors are learning more about the wider effects of the injections, from lowering blood pressure to helping people quit ...
Semaglutide and similar GLP-1 drugs are poised to become frontline treatments for a severe form of liver disease.
Interim results from the Phase III ESSENCE trial published in The New England Journal of Medicine show once-weekly ...
Enhanced weight loss effects of NT-0796 and semaglutide in combination ...
20h
inews.co.uk on MSN1.5m Britons a month pay for weight-loss jabs - and pharmacies 'ready' to step upHigh-street pharmacies are ready to provide the jabs on the NHS and boost take-up for all, says senior pharmacist ...
14don MSN
Savvy pharma-stock investors know that an oral GLP-1 drug from Novo Nordisk called Rybelsus has been on the market as a ...
Eli Lilly suit against Houston’s Empower Pharmacy is a battle over access to a multi-billion dollar market for weight loss ...
Health service to make medications Mounjaro and Wegovy available after short consultation as part of war on obesity ...
The first GLP-1 weight-loss pill is a step closer to hitting the market. Eli Lilly said its experimental pill met its goals ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results